Table 1 Drug-resistance markers analyzed in the two high-throughput microbead-based assays
DR Markers assesed | TB-SPRINT | TB-SNPID |
|---|---|---|
rpoB_176_mut | x | |
rpoB_516_GAC_wt | x | |
rpoB_516_GTC_mut1 | x | x |
rpoB_516_TAC_mut2 | x | |
rpoB_522 | x | |
rpoB_526_CAC_wt | x | |
rpoB_526_TAC_mut1 | x | x |
rpoB_526_GAC_mut2 | x | x |
rpoB_531_TCG_wt | x | x |
rpoB_531_TTG_mut1 | x | |
rpoB_531_TGG_mut2 | x | |
katG_315_AGC_wt | x | x |
katG_315_ACC_mut1 | x | |
katG_315_AAC_mut2 | x | |
inhA_-15_C_wt | x | |
inhA_-15_T_mut1 | x | |
inhA_-16_A_wt | ||
inhA_-16_G_mut1 | ||
inhA_-16_G_wt | ||
inhA_-8_T_wt | ||
inhA_-8_A_mut1 | x | |
gyrA_90-91_GCGTCG_wt | x | |
gyrA 94_wt_GAC | x | |
rrs 1401_wt_A | x | |
rrs1402_wt_C | x | |
eis_(−10A)_CACAA | x | |
eis_(−14 T)_TACAG | x | |
rpsl-43 | x | |
rpsl-88 | x | |
rplC-460 | x | |
Reference | Gomgnimbou et al. 2012; Gomgnimbou et al. 2013 | Bergval et al. 2012; Sengstake et al. 2014 |